BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1970507)

  • 1. Neither adrenergic nor cholinergic antagonists in the central nervous system affect 2-deoxy-D-glucose(2-DG)-induced hyperglycemia.
    Iguchi A; Gotoh M; Matsunaga H; Yatomi A; Uemura K; Miura H; Kunoh Y; Tamagawa T; Sakamoto N
    Brain Res; 1990 Mar; 510(2):321-5. PubMed ID: 1970507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neostigmine-induced hyperglycemia is mediated by central muscarinic receptor in fed rats.
    Iguchi A; Yatomi A; Gotoh M; Matsunaga H; Uemura K; Miura H; Satake T; Tamagawa T; Sakamoto N
    Brain Res; 1990 Jan; 507(2):295-300. PubMed ID: 2337769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in plasma glucose concentration after intracerebroventricular injection of N,O'-dibutyryl cyclic adenosine 3',5'-monophosphate.
    Iguchi A; Gotoh M; Matsunaga H; Ohuchi M; Nomura T; Sakamoto N
    Endocrinology; 1986 Jul; 119(1):125-9. PubMed ID: 2873022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relative importance of nervous system and hormones to the 2-deoxy-D-glucose-induced hyperglycemia in fed rats.
    Matsunaga H; Iguchi A; Yatomi A; Uemura K; Miura H; Gotoh M; Mano T; Sakamoto N
    Endocrinology; 1989 Mar; 124(3):1259-64. PubMed ID: 2563682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperglycaemic effect of glucagon administered intracerebroventricularly in the rat.
    Marubashi S; Tominaga M; Katagiri T; Yamatani K; Yawata Y; Hara M; Sasaki H
    Acta Endocrinol (Copenh); 1985 Jan; 108(1):6-10. PubMed ID: 2857512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent involvement of autonomic nervous system in hyperglycemia due to 2-deoxy-D-glucose.
    Yamamoto H; Nagai K; Nakagawa H
    Am J Physiol; 1988 Dec; 255(6 Pt 1):E928-33. PubMed ID: 2904768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central nervous system-mediated glucagon secretion is enhanced by alpha 2-adrenoreceptor activation.
    Iguchi A; Gotoh M; Matsunaga H; Yatomi A; Uemura K; Miura H; Satake T; Tamagawa T; Sakamoto N
    Endocrinology; 1989 Sep; 125(3):1581-6. PubMed ID: 2569393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic effect of 2-deoxy-D-glucose on plasma glucagon levels in conscious rats.
    Haito K; Takeda A; Kagawa S; Shimizu S; Matsuoka A
    Horm Metab Res; 1984 Dec; 16 Suppl 1():110-3. PubMed ID: 6398250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe refractory thrombocytopenia, dengue hemorrhagic fever, and intravenous anti-D immune globulin.
    Wiwanitkit V
    Pediatr Hematol Oncol; 2012 Mar; 29(2):206-7; author reply 208-9. PubMed ID: 22376021
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of 2-deoxy-glucose-induced glucagon secretion by muscarinic and alpha-adrenoceptor blockade in the mouse.
    Karlsson S; Ahrén B
    Diabetes Res Clin Pract; 1987; 3(4):239-42. PubMed ID: 2887409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism of 2-deoxy-glucose-induced insulin secretion in the mouse.
    Karlsson S; Bood M; Ahrén B
    J Auton Pharmacol; 1987 Jun; 7(2):135-44. PubMed ID: 3308892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 2-deoxy-D-glucose on plasma somatostatin levels in conscious dogs.
    Wasada T; Dobbs RE; Harris V; Unger RH
    Endocrinology; 1981 Apr; 108(4):1222-7. PubMed ID: 6110537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noncholinergic nonadrenergic inhibitory innervation of the canine pylorus.
    Mir SS; Telford GL; Mason GR; Ormsbee HS
    Gastroenterology; 1979 Jun; 76(6):1443-8. PubMed ID: 437443
    [No Abstract]   [Full Text] [Related]  

  • 14. Peptide YY antagonizes beta-adrenergic-stimulated release of insulin in dogs.
    Greeley GH; Lluis F; Gomez G; Ishizuka J; Holland B; Thompson JC
    Am J Physiol; 1988 Apr; 254(4 Pt 1):E513-7. PubMed ID: 2895586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-deoxy-D-glucose-induced hyperglycemia: role for direct sympathetic nervous system activation of liver glucose output.
    Pascoe WS; Smythe GA; Storlien LH
    Brain Res; 1989 Dec; 505(1):23-8. PubMed ID: 2611676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandins affect the central nervous system to produce hyperglycemia in rats.
    Yatomi A; Iguchi A; Yanagisawa S; Matsunaga H; Niki I; Sakamoto N
    Endocrinology; 1987 Jul; 121(1):36-41. PubMed ID: 3474143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of autonomic nervous system in the time-dependent hyperglycemia induced by intracranial injection of D-mannitol and D-glucose.
    Yamamoto H; Nagai K; Nakagawa H
    Chronobiol Int; 1984; 1(1):27-35. PubMed ID: 6152873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma insulin and glucagon responses to intravenous infusion of propionate and their autonomic control in sheep.
    Sano H; Hattori N; Todome Y; Tsuruoka J; Takahashi H; Terashima Y
    J Anim Sci; 1993 Dec; 71(12):3414-22. PubMed ID: 7904990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centrally injected atropine reduces hyperglycemia caused by 2-DG or immobilization stress in awake rats.
    Brito NA; Brito MN; Timo-Iaria C; Kettelhut IC; Migliorini RH
    Physiol Behav; 2001 Jan; 72(1-2):175-9. PubMed ID: 11239995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperglycemia induced by electrical stimulation of lateral part of dorsal parabrachial nucleus.
    Fujiwara T; Nagai K; Takagi S; Nakagawa H
    Am J Physiol; 1988 Apr; 254(4 Pt 1):E468-75. PubMed ID: 2895585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.